“…The first hypervirulent Kp endogenous endophthalmitis was reported in 1986 in Taiwan, in a patient with hepatic abscess without any underlying hepatobiliary pathology, raising attention about a new invasive strain [ 8 , 9 , 10 ]. Subsequent clinical trials reported that an epidemiologic shift in the epidemiology of cryptogenic liver abscess, with a growing number of case reports and subsequent clinical studies on larger patient groups signaling endemic growth of hvKp infections, accounting for 80% of cases in the Asian Pacific rim [ 11 , 12 , 13 , 14 , 15 , 16 , 17 ], and emerging in other regions such as the US, Australia, South Africa and recently in Europe [ 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ], characterized by a high rate of metastatic septic dissemination, endophthalmitis and CNS complications being among the most common.…”